UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)
PRO-PHARMACEUTICALS, INC.
(Name of Issuer)
Common Stock, $.001 par value
(Title of Class of Securities)
| 74267T109 (CUSIP Number) |
December 31, 2004
(Date of Event which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
| CUSIP No. 74267T109 | Page 2 of 5 |
| 1 | NAME OF REPORTING PERSON
David Platt
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
|||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
|||
| 3 | SEC USE ONLY
|
|||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5 SOLE VOTING POWER
4,531,868 6 SHARED VOTING POWER
10,879 7 SOLE DISPOSITIVE POWER
4,531,868 8 SHARED DISPOSITIVE POWER
10,879 |
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,542,747 |
|||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
| ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
16.6% |
|||
| 12 | TYPE OF REPORTING PERSON
IN |
| CUSIP No. 74267T109 | Page 3 of 5 |
The Statement on Schedule 13G, dated January 21, 2002, filed by David Platt, as amended by Amendment No. 1, dated February 9, 2004, is hereby amended and restated in its entirety to read as follows:
| Item 1 |
(a). |
Name of Issuer:
Pro-Pharmaceuticals, Inc. |
||||||||||
| Item 1 |
(b). |
Address of Issuer’s Principal Executive Offices:
189 Wells Avenue Newton, MA 02459 |
||||||||||
| Item 2 |
(a). |
Name of Person Filing:
David Platt |
||||||||||
| Item 2 |
(b). |
Address of Principal Business Office or, if None, Residence:
189 Wells Avenue Newton, MA 02459 |
||||||||||
| Item 2 |
(c). |
Citizenship:
United States |
||||||||||
| Item 2 |
(d). |
Title of Class of Securities:
Common Stock, $.001 par value |
||||||||||
| Item 2 |
(e). |
CUSIP Number:
74267T109 |
||||||||||
| Item 3. |
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: | |||||||||||
| (a) | ¨ | Broker or dealer registered under Section 15 of the Exchange Act. | ||||||||||
| (b) | ¨ | Bank as defined in Section 3(a)(6) of the Exchange Act. | ||||||||||
| (c) | ¨ | Insurance company as defined in Section 3(a)(19) of the Exchange Act. | ||||||||||
| (d) | ¨ | Investment company registered under Section 8 of the Investment Company Act. | ||||||||||
| (e) | ¨ | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). | ||||||||||
| (f) | ¨ | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). | ||||||||||
| (g) | ¨ | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). | ||||||||||
| (h) | ¨ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. | ||||||||||
| (i) | ¨ | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. | ||||||||||
| (j) | ¨ | Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Not Applicable | ||||||||||
| CUSIP No. 74267T109 | Page 4 of 5 |
| Item 4. |
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
|||||||||
| (a) | Amount beneficially owned:
4,542,747* |
|||||||||
| (b) | Percent of class:
16.6%** |
|||||||||
| (c) | Number of shares as to which the person has: | |||||||||
| (i) | Sole power to vote or direct the vote:
4,531,868 |
|||||||||
| (ii) | Shared power to vote or to direct the vote:
10,879 |
|||||||||
| (iii) | Sole power to dispose or to direct the disposition of:
4,531,868 |
|||||||||
| (iv) | Shared power to dispose or to direct the disposition of:
10,879 |
|||||||||
| * Includes 7,379 shares, as well as 3,500 shares issusable upon the exercise of an immediately exercisable share purchase warrant, owned by Dr. Platt’s wife, as to which Dr. Platt disclaims beneficial ownership.
** Based on 27,315,411 shares outstanding as of December 31, 2004. |
||||||||||
| Item 5. |
Ownership of Five Percent or Less of a Class.
Not Applicable |
|||||||||
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable |
|||||||||
| Item 7. |
Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable | |||||||||
| Item 8. |
Identification and Classification of Members of the Group.
Not Applicable |
|||||||||
| Item 9. |
Notice of Dissolution of Group.
Not Applicable |
|||||||||
| Item 10. |
Certification.
Not Applicable |
|||||||||
| CUSIP No. 74267T109 | Page 5 of 5 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| Date: February 9, 2004 |
/s/ David Platt | |
| David Platt |